Birdwatch Note Rating
2023-08-26 08:50:10 UTC - HELPFUL
Rated by Participant: D2794165AA6D061A7E4F5C53E6E4D81A4B1D98F9C94D9098ED3B03E677CA63A3
Participant Details
Original Note:
EBC-46 has shown efficacy to reduce cancer in animal studies only. Clinical trials have since commenced for skin, head and neck, and soft tissue cancers in humans. In 2020 the FDA approved an EBC-46–based medication Stelfonta, to treat mast cell cancer in dogs. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/
All Note Details